GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **3851 - 3875** of **4050** in total

« First

‹ Prev

…

151

152

153

154

155

156

157

158

159

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▲	Arbitrary Fluorescence Units (AFU)
IgA	Patient 2	24	mild	G94576MN	502
IgG	Patient 2	15	mild	G94576MN	9823
IgG	Patient 2	24	mild	G94576MN	9703
IgM	Patient 2	15	mild	G94576MN	186
IgA	Patient 2	3	mild	G94576MN	579
IgG	Patient 2	3	mild	G94576MN	19730
IgM	Patient 2	24	mild	G94576MN	215
IgM	Patient 2	3	mild	G94576MN	327
IgA	Patient 3	-180	mild	G94576MN	253
IgA	Patient 3	11	mild	G94576MN	434
IgG	Patient 3	-180	mild	G94576MN	49
IgM	Patient 3	-180	mild	G94576MN	58
IgA	Patient 3	4	mild	G94576MN	414
IgG	Patient 3	11	mild	G94576MN	81
IgG	Patient 3	4	mild	G94576MN	87
IgM	Patient 3	11	mild	G94576MN	85
IgM	Patient 3	4	mild	G94576MN	83
IgA	Patient 4	12	mild	G94576MN	386
IgG	Patient 4	12	mild	G94576MN	149
IgM	Patient 4	12	mild	G94576MN	123
IgA	Patient 1	10	moderate	G96557TJ	403
IgA	Patient 1	22	moderate	G96557TJ	452
IgA	Patient 1	6	moderate	G96557TJ	406
IgG	Patient 1	10	moderate	G96557TJ	28
IgG	Patient 1	22	moderate	G96557TJ	42